Mahindra & Mahindra Executes Novation Agreement for Life Insurance Joint Venture

1 min read     Updated on 25 Apr 2026, 09:28 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Mahindra & Mahindra has executed a Novation and Amendment Agreement with Manulife, transferring all rights and obligations from Manulife to its wholly owned subsidiary Manulife Holdings (Bermuda) Limited for their life insurance joint venture. The transaction maintains all original JV terms while completing necessary regulatory compliance and exchange notifications.

powered bylight_fuzz_icon
38561899

*this image is generated using AI for illustrative purposes only.

Mahindra & Mahindra has executed a Novation and Amendment Agreement with Manulife and Manulife Holdings (Bermuda) Limited, marking an important development in their joint venture arrangement for the life insurance business. The agreement was executed under Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Transaction Details

The novation agreement involves the complete transfer of rights, interests, and obligations from Manulife to its wholly owned subsidiary, Manulife Holdings (Bermuda) Limited. This transfer is in accordance with the original Joint Venture Agreement executed for the incorporation of a joint venture company to carry on life insurance business and activities incidental or ancillary thereto.

Transaction Details: Information
Reference Number: M&M/SEC/2026-27/012
Date of Execution: 24 April 2026 at 12.44 p.m.
Parties Involved: Mahindra & Mahindra, Manulife, Manulife Holdings (Bermuda) Limited
Transaction Type: Novation and Amendment Agreement
Transfer Direction: From Manulife to Manulife Bermuda
Business Purpose: Life insurance and related activities

Key Provisions

Pursuant to the agreement, Manulife has transferred, assigned, and novated all its rights, interests, and obligations under the Joint Venture Agreement to Manulife Bermuda. Manulife Bermuda has assumed all rights and obligations of Manulife under the JVA and shall be bound by the terms and conditions of the JVA. All other terms and conditions of the original Joint Venture Agreement remain unchanged.

Regulatory Compliance

The company has fulfilled all regulatory disclosure requirements under the transaction. The intimation regarding this development has been uploaded on the Company's website at mahindra.com and has been communicated to multiple stock exchanges.

Exchange Communications: Details
National Stock Exchange: Scrip Symbol M&M
BSE Limited: Scrip Code 500520
International Exchanges: Luxembourg Stock Exchange, London Stock Exchange Plc
ISIN Code: USY541641194
Company Secretary: Sailesh Kumar Daga (FCS: 4164)

The agreement represents a structural reorganization within the Manulife group while maintaining the fundamental terms of the life insurance joint venture partnership with Mahindra & Mahindra.

Historical Stock Returns for Mahindra & Mahindra

1 Day5 Days1 Month6 Months1 Year5 Years
-1.60%-7.35%-3.02%-15.56%+0.69%+321.19%

How might this corporate restructuring within Manulife impact the strategic direction and growth plans of the life insurance joint venture?

Will Manulife Holdings (Bermuda) Limited's involvement change the regulatory oversight or compliance requirements for the joint venture operations?

Could this transfer signal Manulife's broader strategy to consolidate its international insurance partnerships under its Bermuda subsidiary?

Mahindra & Mahindra Patent Portfolio Expands 20-Fold to 1334 Patents Over Decade

1 min read     Updated on 23 Apr 2026, 04:25 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Mahindra & Mahindra has achieved exceptional growth in its patent portfolio, expanding from 56 granted patents to 1334 patents over a 10-year period. This 20-fold increase demonstrates the company's significant investment in research and development activities and strengthens its position as an innovation-focused automotive manufacturer.

powered bylight_fuzz_icon
38487355

*this image is generated using AI for illustrative purposes only.

Mahindra & Mahindra has demonstrated remarkable growth in its intellectual property portfolio, with its patent holdings expanding dramatically over the past decade. The automotive manufacturer has successfully increased its granted patents from 56 to 1334, representing a substantial 20-fold growth in its innovation assets.

Patent Portfolio Growth Overview

The company's intellectual property expansion showcases its commitment to research and development initiatives. This significant increase in patent grants indicates sustained investment in technological innovation and product development across various business segments.

Patent Metrics: Details
Initial Patent Count: 56
Current Patent Count: 1334
Growth Multiple: 20x
Time Period: 10 years

Strategic Innovation Focus

The 20-fold increase in patent portfolio reflects Mahindra & Mahindra's strategic emphasis on innovation-driven growth. This expansion in intellectual property assets strengthens the company's competitive position in the automotive and related industries. The substantial growth in granted patents demonstrates the organization's ability to translate research investments into tangible intellectual property outcomes.

Industry Implications

The dramatic expansion of the patent portfolio from 56 to 1334 granted patents positions the company as an innovation leader in its sector. This intellectual property growth supports the manufacturer's long-term strategic objectives and enhances its technological capabilities across multiple business verticals.

Historical Stock Returns for Mahindra & Mahindra

1 Day5 Days1 Month6 Months1 Year5 Years
-1.60%-7.35%-3.02%-15.56%+0.69%+321.19%

How will Mahindra's expanded patent portfolio impact its competitive positioning in the electric vehicle market?

What revenue streams could emerge from licensing these 1334 patents to other automotive manufacturers?

Which specific technology areas are likely to drive Mahindra's next phase of patent applications and R&D investment?

More News on Mahindra & Mahindra

1 Year Returns:+0.69%